Radiopharm Theranostics Files Feb 2025 6-K Report

Ticker: RDPTF · Form: 6-K · Filed: Feb 28, 2025 · CIK: 1949257

Radiopharm Theranostics Ltd 6-K Filing Summary
FieldDetail
CompanyRadiopharm Theranostics Ltd (RDPTF)
Form Type6-K
Filed DateFeb 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Radiopharm Theranostics filed its monthly 6-K report for Feb 2025, confirming its foreign private issuer status and Australian address.

AI Summary

Radiopharm Theranostics Limited filed a Form 6-K on February 28, 2025, reporting for the month of February 2025. The company is a foreign private issuer and will file annual reports under Form 20-F. Its principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Why It Matters

This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' ongoing reporting obligations as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

  • Radiopharm Theranostics Limited (company) — Registrant
  • 001-41621 (company) — Commission File Number
  • Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
  • Form 20-F (company) — Annual report form
  • Form 6-K (company) — Filing type

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes public in its home country, files with a stock exchange, or distributes to its security holders.

What is Radiopharm Theranostics Limited's filing status?

Radiopharm Theranostics Limited is a foreign private issuer and will file annual reports under Form 20-F.

Where is Radiopharm Theranostics Limited's principal executive office located?

Its principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

What period does this Form 6-K report cover?

This Form 6-K reports for the month of February 2025.

What is the Commission File Number for Radiopharm Theranostics Limited?

The Commission File Number for Radiopharm Theranostics Limited is 001-41621.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on February 28, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.